William Blair & Company
EDIT icon

William Blair & Company’s Editas Medicine EDIT Stock Holding History

William Blair & Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,353
Closed -$368K – 1884
2022
Q1 		$368K Buy
19,353
+4,575
+31% +$85K ﹤0.01% 1281
2021
Q4 		$392K Buy
14,778
+1,803
+14% +$62.1K ﹤0.01% 1311
2021
Q3 		$533K Sell
12,975
-30
-0.2% -$1.64K ﹤0.01% 1137
2021
Q2 		$737K Sell
13,005
-45
-0.3% -$1.66K ﹤0.01% 1017
2021
Q1 		$548K Buy
13,050
+1,350
+12% +$76.9K ﹤0.01% 1088
2020
Q4 		$820K Hold
11,700
– – ﹤0.01% 926
2020
Q3 		$328K Buy
11,700
+900
+8% +$29.3K ﹤0.01% 1108
2020
Q2 		$319K Buy
10,800
+150
+1% +$3.92K ﹤0.01% 1069
2020
Q1 		$211K Sell
10,650
-600
-5% -$15.1K ﹤0.01% 1149
2019
Q4 		$333K Hold
11,250
– – ﹤0.01% 1137
2019
Q3 		$256K Sell
11,250
-3,283
-23% -$81.3K ﹤0.01% 1181
2019
Q2 		$360K Hold
14,533
– – ﹤0.01% 1094
2019
Q1 		$355K Sell
14,533
-938
-6% -$21.2K ﹤0.01% 1086
2018
Q4 		$352K Buy
15,471
+2,171
+16% +$59.1K ﹤0.01% 1034
2018
Q3 		$423K Buy
13,300
+1,700
+15% +$54.9K ﹤0.01% 1014
2018
Q2 		$416K Buy
+11,600
New +$411K ﹤0.01% 1009

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

William Blair & Company's EDIT Position: Q2 2022 in Review

William Blair & Company sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 19,353 shares — an estimated $368K sold.

William Blair & Company first reported a position in EDIT in Q2 2018 and held it in 16 quarters. The position peaked at $820K in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • William Blair & Company reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • William Blair & Company sold 19,353 Editas Medicine shares in Q2 2022, an estimated $368K.
  • William Blair & Company first reported a position in Editas Medicine in Q2 2018 and held it in 16 quarters.
  • William Blair & Company's Editas Medicine position peaked at $820K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.